What is Hepar Bioscience?
Established in 2014, Hepar Bioscience operates as a critical link in the international pet food supply chain. The company specializes in the production of high-quality, essential ingredients, including concentrated peptone and processed proteins such as dried pork, turkey, and bacon. By maintaining a state-of-the-art production facility, Hepar Bioscience serves as a foundational partner for premium pet food brands, ensuring that manufacturers have access to consistent, high-grade components. Their market position is defined by a commitment to quality control and reliable logistics, which are vital for maintaining the integrity of the global pet food market.
How much funding has Hepar Bioscience raised?
Hepar Bioscience has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Hepar Bioscience
PPP
Public-Private Partnership
What's next for Hepar Bioscience?
Following this late-stage capital injection, Hepar Bioscience is expected to prioritize the optimization of its production capacity and the expansion of its international distribution network. As the pet food industry continues to demand higher standards of ingredient transparency and quality, the company is likely to leverage this financing to enhance its processing technologies and potentially explore new product verticals. The strategic focus will remain on scaling operations to meet the growing demand from global pet food manufacturers, ensuring that Hepar Bioscience remains a preferred supplier in an increasingly competitive landscape.
See full Hepar Bioscience company page
